From targeted phishing attacks to medical identity theft, there’s a lot hackers can do with this sensitive personal and ...

The health system is among those facing lawsuits claiming it allowed third-party tracking to collect information about users ...

Atrium Health has issued an apology for a potential disclosure of patients' personal information that predates the COVID-19 ...

Researchers at the NYU Pain Research Center have found a new receptor for nerve growth factor that plays an important role in ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced new frontline data featuring TECVAYLI®▼ (teclistamab) from two investigational studies in patients with newly diagnosed ...

Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

Teclistamab is an off-the-shelf (or ready to use) bispecific antibody. 6 Teclistamab, a subcutaneous injection, redirects T-cells through two cellular targets (BCMA and CD3) to activate the body's ...

Through a recent notice, the Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has invited ...

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and ...

AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...

LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial ...